Valuation: Novartis AG

Market Cap 278B 244B 225B 207B 392B 26,822B 398B 2,690B 1,055B 13,121B 1,044B 1,022B 45,181B P/E 2026 *
21.2x
P/E 2027 * 18x
Enterprise Value 310B 272B 251B 231B 437B 29,907B 443B 2,999B 1,176B 14,630B 1,165B 1,139B 50,379B EV / Sales 2026 *
5.45x
EV / Sales 2027 * 5.08x
Free-Float
91.66%
Yield 2026 *
2.93%
Yield 2027 * 3.02%
1 day-1.52%
1 week-0.95%
Current month-2.75%
1 month+4.06%
3 months+3.60%
6 months+6.52%
Current year+12.32%
1 week 121.06
Extreme 121.06
125.36
1 month 117.96
Extreme 117.96
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.2
Extreme 91.2
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-0.95%+33.38%+38.39% 284B
-2.73%-3.51%+48.62%+152.87% 1,051B
-1.67%-3.18%+52.00%+56.75% 609B
-0.44%+2.14%+33.88%+84.04% 450B
-0.75%-1.46%+28.32%+22.33% 330B
-1.70%-3.54%+20.26%+17.88% 263B
-0.58%+1.78%-20.89%-38.37% 223B
-0.58%+0.21%+23.55%+56.94% 198B
-0.80%+2.60%+23.09%+68.71% 167B
-1.20%+2.40%+1.14%-32.08% 143B
Average -0.62%+0.85%+24.34%+42.74% 371.78B
Weighted average by Cap. -0.14%+0.16%+33.94%+71.44%

Financials

2026 *2027 *
Net sales 56.91B 49.87B 46.09B 42.4B 80.13B 5,488B 81.36B 550B 216B 2,684B 214B 209B 9,244B 60.31B 52.86B 48.85B 44.93B 84.93B 5,816B 86.23B 583B 229B 2,845B 226B 222B 9,797B
Net income 14.08B 12.34B 11.4B 10.49B 19.82B 1,358B 20.13B 136B 53.39B 664B 52.86B 51.71B 2,287B 15.64B 13.71B 12.67B 11.65B 22.03B 1,509B 22.37B 151B 59.32B 738B 58.74B 57.46B 2,541B
Net Debt 32B 28.04B 25.92B 23.84B 45.06B 3,086B 45.75B 309B 121B 1,509B 120B 118B 5,198B 28.48B 24.96B 23.07B 21.22B 40.1B 2,746B 40.72B 275B 108B 1,343B 107B 105B 4,626B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
20/07/26 CHF 123.10 -1.52% 1,700,014
17/07/26 CHF 125.00 +1.41% 2,979,184
16/07/26 CHF 123.26 +1.03% 2,306,603
15/07/26 CHF 122.00 -0.34% 1,730,393
14/07/26 CHF 122.42 -1.73% 2,431,098
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
151.94USD
Average target price
152.73USD
Spread / Average Target
+0.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock